TRANSCEND BIOLOGICS
Live / Registered — Registered (as of 14 Apr 2026)
What this means for you
Registered since 14 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Apr 2032: the §8 declaration of use).
Record
- Serial number
- 97690309
- Registration number
- 8215110
- Mark type
- Word mark
- Filed
- 23 Nov 2022
- Published for opposition
- 16 Jan 2024
- Registered
- 14 Apr 2026
- Next maintenance filing
- §8 declaration of use, due by 14 Apr 2032 (grace period to 14 Oct 2032)
- Attorney of record
- Vincent J. Allen
Goods and services
- Class 005 — Pharmaceuticals: Blood containers for veterinary and human medical and clinical use sold partially filled with an anticoagulant additive solution
Owner
- Transcend Biologics, LLC, The Colony, TX, US
- Transcend Biologics, LLC, The Colony, TX, US
- Transcend Biologics, LLC, The Colony, TX, US
Prosecution history
- 14 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 20 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Sept 2025 — USE AMENDMENT FILED
- 19 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 14 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2025 — SOU EXTENSION 2 GRANTED
- 13 Feb 2025 — SOU EXTENSION 2 FILED
- 13 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2024 — SOU EXTENSION 1 GRANTED
- 12 Sept 2024 — SOU EXTENSION 1 FILED